semaglutide generic date patent expiry in India opens up huge opportunity for drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent Canada approves generic semaglutide from

Understanding which side effects are most common and which are rare helps patients set realistic expectations and communicate effectively with their healthcare providers

People may suffer embarrassment and social anxiety, trouble eating that leads to weight loss, nausea, sleep loss, and chronic fatigue

The upper arm The back of the upper arm is the third approved location

The authors of the study concluded that the GLP-1 receptor agonist lixisenatide had a three-point beneficial effect, when compared with placebo, in the change over a 12-month period from a baseline value of approximately 15 points on a 132-point scale measuring motor disability. The active arm improved 0.04 points in the lixisenatide group and worsened 3.04 points in the placebo group